End in sight for U.S. insider trading case over healthcare leaks
By Jonathan Stempel NEW YORK (Reuters) -A long-running federal insider trading case based on leaks about planned changes to Medicare reimbursement rates will likely end with no convictions, after the remaining defendants agreed to enter deferred prosecution agreements. Theodore Huber and Robert Olan, who were partners at the hedge fund Deerfield Management, and David Blaszczak,…